Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Pancreatic Neoplasms 3Neoplasms 2Disease 2Spinal Cord Neoplasms 1Rectal Neoplasms 1Pleural Effusion 1Pleural Diseases 1Pituitary Neoplasms 1Parkinson Disease 1Pancreatitis, Chronic 1Pancreatic carcinoma, familial 1Nervous System Diseases 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mesothelioma 1Hereditary pancreatitis 1Hematologic Diseases 1Epilepsy 1Diabetes Mellitus 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiotoxicity 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Bone Marrow Diseases 1

Interventions

Sirolimus 4LY3295668 erbumine 3Everolimus 3Medical Marijuana 2Anticonvulsants 2ziprasidone 1perampanel 1enzalutamide 1clevidipine 1brivaracetam 1Zolpidem 1Warfarin 1Vigabatrin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Topotecan 1Tobramycin 1Therapeutic Touch 1Temozolomide 1TAS-119 1Surgical Procedures, Operative 1Sulfasalazine 1Spironolactone 1Sevoflurane 1Sevelamer 1Saline Solution 1Rocuronium 1Registries 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Epilepsy × Clinical Laboratory Techniques × Clear all
NCT00060541 2026-06-01

Evaluation and Treatment of Neurosurgical Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
5,000 enrolled
CNSEndocrine

Brain Neoplasms, Epilepsy, Nervous System Diseases, Parkinson Disease, Pituitary Neoplasms, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡